AMD Delivers Leadership Portfolio of Data Center AI Solutions with AMD Instinct MI300 Series
December 06, 2023 15:00 ET
|
Advanced Micro Devices, Inc.
— Dell Technologies, Hewlett Packard Enterprise, Lenovo, Meta, Microsoft, Oracle, Supermicro and others showcase AMD hardware for high performance computing and generative AI — — ROCm 6 open...
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
December 04, 2023 14:45 ET
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. APPOINTS
DESSY BONEVA, MD, FACS TO THE BOARD OF DIRECTORS Dr. Boneva is an experienced surgeon skilled in trauma, surgical
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
December 01, 2023 12:32 ET
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. ANNOUNCES HIRING OF INTERIM CFO
Virender Ahluwalia will serve as Interim Chief Financial Officer
Point sur la procédure de redressement judiciaire : dépôt d’une offre de reprise auprès des Administrateurs Judiciaires
November 20, 2023 11:45 ET
|
Pixium Vision
Point sur la procédure de redressement judiciaire : dépôt d’une offre de reprise auprès des Administrateurs Judiciaires Paris, France, 20 novembre 2023 - 17h45 CET - Pixium Vision SA (Euronext...
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators
November 20, 2023 11:45 ET
|
Pixium Vision
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators Paris, France, November 20, 2023 – 5:45 pm (CET) – Pixium Vision SA (Euronext Growth...
Latest Top500 List Highlights Several World's Fastest and Most Efficient Supercomputers Powered by AMD
November 14, 2023 09:00 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) showcased its continued leadership in high performance computing (HPC) at Supercomputing 23. AMD EPYC™ processors and...
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique sévère
November 14, 2023 01:00 ET
|
Pixium Vision
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique sévère L'étude vient confirmer les résultats à 36 mois : l’utilisation de la prothèse sous-rétinienne est possible,...
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
November 14, 2023 01:00 ET
|
Pixium Vision
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming...
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
November 09, 2023 12:58 ET
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
November 08, 2023 05:45 ET
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC and AVANIA CRO CONTRACT to GUIDE the DEVELOPMENT of TWO DRUG THERAPIES and the RETINALCAM™ IMAGE VISUALIZATION DEVICE